1:18-cv-00677
N.D.N.Y.Nov 1, 2019Background
- MVP Health Plan (Plaintiff) contracted with Cotiviti (Defendant) to filter and submit Medicare Advantage risk-adjustment (RAPS) data to CMS under a 2008 master services agreement (amended 2009, 2011).
- Plaintiff alleges Cotiviti’s filtering logic was deeply flawed, causing erroneous RAPS submissions that led to underpayments, overpayments refunds, and distorted annual bids—resulting in multi‑million dollar losses.
- Cotiviti allegedly concealed the defects, represented its systems were operating correctly (including a 2016 SOC report and statements during a 2016 "sweepback"), and then sought a 2017 contract containing broad liability‑limiting clauses.
- Plaintiff claims it was fraudulently induced to sign the 2017 contract and that the misrepresentations were collateral to the agreement; it sued for breach(es), fraudulent inducement, rescission, declaratory relief, and unjust enrichment.
- Defendant moved to dismiss under Rules 12(b)(6) and 9(b), to obtain declaratory relief, and to strike damages/fee and jury demands; the court first addressed whether the 2017 contract was fraudulently induced.
- The court denied the motion to dismiss the fraudulent‑inducement claim (third cause of action) as sufficiently pleaded under Iqbal/Twombly and Rule 9(b), reserved other relief, and referred pretrial matters to a magistrate judge.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Sufficiency of fraudulent‑inducement pleading | Alleges specific misrepresentations (SOC, sweepback statements, reasons for 2017 contract), admission of defects, and reliance | Claims allegations are conclusory/duplicative of contract claims and fail Rule 9(b) particularity | Court: pleaded with required particularity and plausibility; claim survives 12(b)(6) and 9(b) challenge |
| Whether fraud duplicates contract remedies | Fraud is collateral/extraneous because misrepresentations about system performance induced new contract | Fraud merely echoes contract breach; therefore duplicative and barred | Court: misrepresentations were collateral to the 2017 contract, allowing parallel fraud claim under Merrill Lynch test |
| Knowledge/motive inference for fraud | Points to Cotiviti admission (May 2017 call), internal statements, and the attractive liability caps in 2017 contract as motive | Argues plaintiff fails to show strong inference of intent or awareness | Court: allegations permit a factfinder to infer Cotiviti knew of defects and intended to limit liability; strong inference adequately pled |
| Effect of ruling on other claims and discovery scope | Fraud claim controls whether 2017 agreement supplants 2008 agreement; discovery should address inducement first | Seeks dismissal of other claims and limits on plaintiff's relief now | Court: reserved ruling on remaining requests; referred case for pretrial management and possible limited discovery focusing on inducement |
Key Cases Cited
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading must state a plausible claim on its face)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (complaint requires factual allegations beyond labels and conclusions)
- Lerner v. Fleet Bank, 459 F.3d 273 (2d Cir. 2006) (Rule 9(b) requires facts giving rise to a strong inference of fraudulent intent)
- Merrill Lynch & Co. Inc. v. Allegheny Energy, Inc., 500 F.3d 171 (2d Cir. 2007) (fraud and contract claims may coexist when fraud is collateral or duty is separate)
- Crigger v. Fahnestock & Co., 443 F.3d 230 (2d Cir. 2006) (elements of fraudulent inducement)
- Mills v. Polar Molecular Corp., 12 F.3d 1170 (2d Cir. 1993) (Rule 9(b) particularity requirements for specifying fraudulent statements)
- Shields v. Citytrust Bancorp, Inc., 25 F.3d 1124 (2d Cir. 1994) (establishing routes to infer fraudulent intent: motive/opportunity or strong circumstantial evidence)
